These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Long-term results of laparoscopic retroperitoneal lymph node dissection (RPLND) in low-stage nonseminomatous germ-cell testicular tumors (NSGCTT) performed by a senior surgeon: 1999-2003]. Pizzocaro G; Schiavo M; Solima S; Vitellaro M; Biasoni N; Nicolai N Urologia; 2010; 77 Suppl 17():50-6. PubMed ID: 21308676 [TBL] [Abstract][Full Text] [Related]
7. Current controversies on the role of retroperitoneal lymphadenectomy for testicular cancer. Mano R; Di Natale R; Sheinfeld J Urol Oncol; 2019 Mar; 37(3):209-218. PubMed ID: 30446455 [TBL] [Abstract][Full Text] [Related]
8. [Post-chemotherapy laparoscopic retroperitoneal lymph node dissection in low volume residual germ cell cancer: a technique to reduce morbidity]. Aufderklamm S; Todenhöfer T; Hennenlotter J; Gakis G; Mischinger J; Mundhenk J; Germann M; Stenzl A; Schwentner C Urologe A; 2013 Aug; 52(8):1097-103. PubMed ID: 23416965 [TBL] [Abstract][Full Text] [Related]
9. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour. Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110 [TBL] [Abstract][Full Text] [Related]
10. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors. Aprikian AG; Herr HW; Bajorin DF; Bosl GJ Cancer; 1994 Aug; 74(4):1329-34. PubMed ID: 8055456 [TBL] [Abstract][Full Text] [Related]
11. Indications, evolving technique, and early outcomes with robotic retroperitoneal lymph node dissection. Werntz RP; Pearce SM; Eggener SE Curr Opin Urol; 2018 Sep; 28(5):461-468. PubMed ID: 29979235 [TBL] [Abstract][Full Text] [Related]